(Q51408910)

5 April 2018

title

Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975-2009). (English)

1 reference

5 April 2018

0 references

0 references

5

1 reference

5 April 2018

Elaine Kingwell

Elaine Kingwell

3

0 references

Afsaneh Shirani

1

Afsaneh Shirani

1 reference

5 April 2018

Yinshan Zhao

2

Yinshan Zhao

1 reference

5 April 2018

Peter Rieckmann

4

Peter Rieckmann

1 reference

5 April 2018

publication date

27 September 2011

1 reference

5 April 2018

Multiple Sclerosis Journal

published in

1 reference

5 April 2018

volume

18

1 reference

5 April 2018

issue

4

1 reference

5 April 2018

page(s)

442-450

1 reference

5 April 2018

https://api.crossref.org/works/10.1177%2F1352458511422097

1 reference

Disability progression in multiple sclerosis is slower than previously reported.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511422097

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511422097

Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511422097

New perspectives in the natural history of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511422097

Modifiable factors influencing relapses and disability in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511422097

Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511422097

Incidence of multiple sclerosis in Møre and Romsdal, Norway from 1950 to 1991. An age-period-cohort analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511422097

Increasing prevalence and incidence of multiple sclerosis in South East Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511422097

Trends in survival and cause of death in Danish patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511422097

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511422097

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511422097

Epstein-Barr virus is associated with grey matter atrophy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511422097

Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511422097

Reconsidering clinical outcomes in Multiple Sclerosis: relapses, impairment, disability and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511422097

Disability as an outcome in MS clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511422097

The changing demographic pattern of multiple sclerosis epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511422097

Anticipation of age at onset in multiple sclerosis: a Sardinian cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511422097

Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458511422097

21 January 2018

Identifiers

DOI

10.1177/1352458511422097

1 reference

5 April 2018

1 reference

5 April 2018